Company intelligence / Profile preview

Phoenix Products

San Antonio, Texas, United Statesphoenixprods.com ↗

Ownership: Private
Development stage: Commercial

Overview

Phoenix Biotechnology has developed natural product extracts from Nerium oleander, particularly focusing on the active compound oleandrin. Preclinical data suggest efficacy in modulating immune responses, inhibiting viral replication by disrupting viral envelopes, and potential benefits in cancer and neurodegenerative disease models. Some products are marketed for immune support and symptom reduction but lack large-scale clinical trial results or regulatory approval for therapeutic claims.

Therapeutic areas: OncologyImmunologyNeurologyInfectious Diseases
Modalities: Natural productSmall molecule
Industry: Biotech

Partnerships

Avila Herbals LLC – exclusive global manufacturing and R&D agreement for certain products including "Oleander 4X" homeopathic medicine

Beyond the preview

Go deeper on Phoenix Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phoenix Products.

Explore the full profile